178 related articles for article (PubMed ID: 24257288)
1. A critical evaluation of the PTW 2D-ARRAY seven29 and OCTAVIUS II phantom for IMRT and VMAT verification.
Hussein M; Adams EJ; Jordan TJ; Clark CH; Nisbet A
J Appl Clin Med Phys; 2013 Nov; 14(6):4460. PubMed ID: 24257288
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.
Hussein M; Rowshanfarzad P; Ebert MA; Nisbet A; Clark CH
Radiother Oncol; 2013 Dec; 109(3):370-6. PubMed ID: 24100148
[TBL] [Abstract][Full Text] [Related]
3. Experimental determination of the "collimator monitoring fill factor" and its relation to the error detection capabilities of various 2D-arrays.
Stelljes TS; Poppinga D; Kretschmer J; Brodbek L; Looe HK; Poppe B
Med Phys; 2019 Apr; 46(4):1863-1873. PubMed ID: 30707450
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
[TBL] [Abstract][Full Text] [Related]
5. Development of a quasi-3D dosimeter using radiochromic plastic for patient-specific quality assurance.
Cho JD; Jin H; Jung S; Son J; Choi CH; Park JM; Kim JS; Kim JI
Med Phys; 2023 Oct; 50(10):6624-6636. PubMed ID: 37408321
[TBL] [Abstract][Full Text] [Related]
6. Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans.
McKenzie EM; Balter PA; Stingo FC; Jones J; Followill DS; Kry SF
Med Phys; 2014 Dec; 41(12):121702. PubMed ID: 25471949
[TBL] [Abstract][Full Text] [Related]
7. Transit and non-transit 3D EPID dosimetry versus detector arrays for patient specific QA.
Olaciregui-Ruiz I; Vivas-Maiques B; Kaas J; Perik T; Wittkamper F; Mijnheer B; Mans A
J Appl Clin Med Phys; 2019 Jun; 20(6):79-90. PubMed ID: 31083776
[TBL] [Abstract][Full Text] [Related]
8. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
Korevaar EW; Wauben DJ; van der Hulst PC; Langendijk JA; Van't Veld AA
Radiother Oncol; 2011 Sep; 100(3):446-52. PubMed ID: 21963288
[TBL] [Abstract][Full Text] [Related]
9. Implementing RapidArc into clinical routine: a comprehensive program from machine QA to TPS validation and patient QA.
Van Esch A; Huyskens DP; Behrens CF; Samsoe E; Sjolin M; Bjelkengren U; Sjostrom D; Clermont C; Hambach L; Sergent F
Med Phys; 2011 Sep; 38(9):5146-66. PubMed ID: 21978060
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry : A step to QA with in vivo EPID dosimetry.
Moustakis C; Ebrahimi Tazehmahalleh F; Elsayad K; Fezeu F; Scobioala S
Strahlenther Onkol; 2020 Feb; 196(2):182-192. PubMed ID: 31925465
[TBL] [Abstract][Full Text] [Related]
11. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
[TBL] [Abstract][Full Text] [Related]
12. On-line quality assurance of rotational radiotherapy treatment delivery by means of a 2D ion chamber array and the Octavius phantom.
Van Esch A; Clermont C; Devillers M; Iori M; Huyskens DP
Med Phys; 2007 Oct; 34(10):3825-37. PubMed ID: 17985628
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA.
Alhazmi A; Gianoli C; Neppl S; Martins J; Veloza S; Podesta M; Verhaegen F; Reiner M; Belka C; Parodi K
Phys Med Biol; 2018 May; 63(11):115002. PubMed ID: 29714714
[TBL] [Abstract][Full Text] [Related]
14. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
15. Pixel response-based EPID dosimetry for patient specific QA.
Han B; Ding A; Lu M; Xing L
J Appl Clin Med Phys; 2017 Jan; 18(1):9-17. PubMed ID: 28291939
[TBL] [Abstract][Full Text] [Related]
16. Biological consequences of MLC calibration errors in IMRT delivery and QA.
Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
[TBL] [Abstract][Full Text] [Related]
17. Comparison of MLC error sensitivity of various commercial devices for VMAT pre-treatment quality assurance.
Saito M; Sano N; Shibata Y; Kuriyama K; Komiyama T; Marino K; Aoki S; Ashizawa K; Yoshizawa K; Onishi H
J Appl Clin Med Phys; 2018 May; 19(3):87-93. PubMed ID: 29500857
[TBL] [Abstract][Full Text] [Related]
18. 3D dose reconstruction of pretreatment verification plans using multiple 2D planes from the OCTAVIUS/Seven29 phantom array.
Calvo O; Stathakis S; Gutiérrez AN; Esquivel C; Papanikolaou N
Technol Cancer Res Treat; 2012 Feb; 11(1):69-82. PubMed ID: 22181333
[TBL] [Abstract][Full Text] [Related]
19. Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.
Lin MH; Koren S; Veltchev I; Li J; Wang L; Price RA; Ma CM
J Appl Clin Med Phys; 2013 May; 14(2):3929. PubMed ID: 23470927
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy dose verification using fluence and portal imaging device.
Sumida I; Yamaguchi H; Das IJ; Kizaki H; Aboshi K; Tsujii M; Yamada Y; Suzuki O; Seo Y; Isohashi F; Ogawa K
J Appl Clin Med Phys; 2016 Jan; 17(1):259-271. PubMed ID: 26894363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
